Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial
- Paul P. Tak
- , Andra Balanescu
- , Vira Tseluyko
- , Silvia Bojin
- , Edit Drescher
- , Dan Dairaghi
- , Shichang Miao
- , Vittorio Marchesin
- , Juan Jaen
- , Thomas J. Schall
- , Pirow Bekker
Research output: Contribution to journal › Article › Academic › peer-review